Kowa Pharmaceuticals Americaincis A Subsidiary Of Japanae S Kowa Companyltd Focused On Developing And Commercializing Pharmaceutical Productsparticularly In Cardiometabolic Therapeuticsestablished In 2008 After Acquiring Proethic Pharmaceuticalsthe Company Is Headquartered In Montgomeryalabamait Operates Within Kowaae S Global Sales Networkwhich Spans Japaneuropeand The U S With A Strong Emphasis On Addressing Cardiovascular Diseasestype 2 Diabetesand Atherosclerosis The Companyae S Flagship Product Is Livaloa Pitavastatin A Statin Used To Lower Cholesterolkowa Pharmaceuticals America Is Committed To Safety And Efficacy In Its Offerings And Primarily Serves Healthcare Providers And Institutionsthe Company Has A Robust Patent Portfoliowith Innovations In Ophthalmologyppar Agonistsand Fatty Acid Derivativesreflecting Its Dedication To Advancing Treatments For Metabolic Disorderskowa Pharmaceuticals America Also Emphasizes Complianceethical Standardsand Professional Development Through Its Sales Training Programs
